Guanghua Cui

Title: The Innovative Contributions of Guanghua Cui

Introduction

Guanghua Cui is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of targeted drug delivery systems. His innovative work focuses on enhancing the therapeutic effects of anti-cancer medications.

Latest Patents

One of Guanghua Cui's notable patents is the "Long-circulating liposome modified with c(RGD-ACP-K)." This invention pertains to a long-circulating liposome that is modified with c(RGD-ACP-K) and includes doxorubicin or a pharmaceutically acceptable salt thereof, such as doxorubicin hydrochloride, as an anti-cancer active agent. The long-circulating liposome is designed to deliver the anti-cancer active agent specifically to tumor neovascular endothelial cells and tumor cells. This targeted delivery system prolongs the circulation time of the liposome in vivo, thereby enhancing the therapeutic effect of anti-tumor medications.

Career Highlights

Guanghua Cui has worked with several companies, including Beijing Greatsun Bio-pharm Technology Co., Ltd and Beijing Greatsun Bto-pharm Technology Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and drug delivery systems.

Collaborations

Guanghua Cui has collaborated with notable colleagues such as Qiang Zhang and Cuishuan Wu. These partnerships have furthered his research and development efforts in the pharmaceutical field.

Conclusion

Guanghua Cui's innovative work in the development of targeted pharmaceutical preparations showcases his commitment to advancing cancer treatment. His contributions, particularly through his patented long-circulating liposome, highlight the importance of targeted drug delivery systems in enhancing therapeutic outcomes.